Transition report pursuant to Rule 13a-10 or 15d-10

Consolidated Statements of Changes in Stockholders' Equity

v3.21.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
Special Voting Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total Stockholder's Equity
Noncontrolling Interest in Consolidated Subsidiary
Balance at Jun. 30, 2018 $ 1,400,063 $ 492 $ 14,563,102 $ (13,163,531) $ 1,400,063
Balance, shares at Jun. 30, 2018     4,922,650          
Issuance of common stock 10,000,000 $ 110 9,999,890 10,000,000
Issuance of common stock, shares     1,099,376          
Issuance of shares in connection with reverse merger 18,878,775 $ 388 18,878,387 18,878,775
Issuance of shares in connection with reverse merger, shares     3,880,282          
Issuance of common stock for compensation in connection with reverse merger 3,393,281 $ 50 3,393,231 3,393,281
Issuance of common stock for compensation in connection with reverse merger, shares     498,073          
Stock-based compensation amortization 490,830 490,830 490,830
Common stock issued upon cashless exercise of options $ 19 (19)
Common stock issued upon cashless exercise of options, shares     189,365          
Net loss (12,403,215) (12,403,215) (12,403,215)
Balance at Jun. 30, 2019 21,759,734 $ 1,059 47,325,421 (25,566,746) 21,759,734
Balance, shares at Jun. 30, 2019     10,589,746          
Adoption of ASC 606 Adjustment 185,826 185,826 185,826
Common stock issued upon warrant exercise 4,247,065 $ 37 4,247,028 4,247,065
Common stock issued upon warrant exercise, shares     369,311          
Common stock issued in business combinations 20,081,466 $ 230 20,081,236 20,081,466
Common stock issued in business combinations, shares     2,299,650          
Acquisition of noncontrolling interests 5,554,011 5,554,011
Stock-based compensation amortization 1,253,234 1,253,234 1,253,234
Forfeitures of restricted shares $ (5) 5
Forfeitures of restricted shares, shares     (54,901)          
Unrealized loss (gains) on Convertible Notes 63,000 63,000 63,000
Net loss (16,384,104) (15,534,345) (15,534,345) (849,759)
Balance at Jun. 30, 2020 31,870,154 $ 1,321 72,906,924 63,000 (41,101,091) 31,870,154 4,704,252
Balance, shares at Jun. 30, 2020     13,203,806          
Balance as of July 1, 2020 36,760,232 $ 1,321 72,906,924 63,000 (40,915,265) 32,055,980 4,704,252
Balance as of July 1, 2020, shares     13,203,806          
Issuance of common stock $ 11,032,380 $ 500 11,031,880 11,032,380
Issuance of common stock, shares 113,375   5,000,000          
Special voting preferred stock issued in business combination $ 25,203,490 $ 25,203,490 25,203,490
Special voting preferred stock issued in business combination, shares   3,294,574            
Conversion of exchangable shares to common $ (4,798,271) $ 63 4,798,208
Conversion of exchangable shares to common, shares   (627,225) 627,225          
Acquisition of noncontrolling interests $ 80 4,695,357 4,695,437 (4,695,437)
Acquisition of noncontrolling interest, shares     800,000          
Stock-based compensation amortization 1,298,540 1,298,540 1,298,540
Settlement of convertible debt 360,000 $ 11 359,989 360,000
Settlement of convertible debt, shares     112,867          
Restricted stock unit vesting $ 15 (15)
Restricted stock unit vesting, shares     157,350          
Unrealized loss (gains) on Convertible Notes (133,000) (133,000) (133,000)
Foreign currency translation adjustments (21,497) (21,497) (21,497)
Net loss (16,966,149) (16,957,334)    
Balance at Dec. 31, 2020 $ 57,533,996 $ 20,405,219 $ 1,990 $ 95,090,883 $ (91,497) $ (57,872,599) $ 57,533,996
Balance, shares at Dec. 31, 2020   2,667,349 19,901,248       (16,957,334) (8,815)